- Home
- VFS vs NUVL Comparison
VFS vs NUVL Comparison
Compare VFS & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- NUVL
- Stock Information
- Founded
- VFS 2017
- NUVL 2017
- Country
- VFS Vietnam
- NUVL United States
- Employees
- VFS N/A
- NUVL N/A
- Industry
- VFS Blank Checks
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- VFS Finance
- NUVL Health Care
- Exchange
- VFS Nasdaq
- NUVL Nasdaq
- Market Cap
- VFS 6.8B
- NUVL 5.6B
- IPO Year
- VFS N/A
- NUVL 2021
- Fundamental
- Price
- VFS $3.60
- NUVL $73.32
- Analyst Decision
- VFS Strong Buy
- NUVL Strong Buy
- Analyst Count
- VFS 4
- NUVL 8
- Target Price
- VFS $8.17
- NUVL $115.50
- AVG Volume (30 Days)
- VFS 468.3K
- NUVL 557.6K
- Earning Date
- VFS 05-23-2025
- NUVL 05-08-2025
- Dividend Yield
- VFS N/A
- NUVL N/A
- EPS Growth
- VFS N/A
- NUVL N/A
- EPS
- VFS N/A
- NUVL N/A
- Revenue
- VFS $1,727,262,130.00
- NUVL N/A
- Revenue This Year
- VFS N/A
- NUVL N/A
- Revenue Next Year
- VFS $44.69
- NUVL N/A
- P/E Ratio
- VFS N/A
- NUVL N/A
- Revenue Growth
- VFS 57.87
- NUVL N/A
- 52 Week Low
- VFS $2.56
- NUVL $55.54
- 52 Week High
- VFS $6.42
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- VFS 58.39
- NUVL 52.53
- Support Level
- VFS $3.52
- NUVL $68.64
- Resistance Level
- VFS $3.82
- NUVL $74.99
- Average True Range (ATR)
- VFS 0.13
- NUVL 3.83
- MACD
- VFS 0.01
- NUVL -0.07
- Stochastic Oscillator
- VFS 61.34
- NUVL 63.35
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.